Guided Therapeutics (GTHP) Treasury Shares (2010 - 2025)
Guided Therapeutics (GTHP) reported Treasury Shares of $132000.0 for Q3 2025, little changed on a YoY basis from $132000.0 in Q3 2024, and little changed sequentially from $132000.0 in Q2 2025.
Guided Therapeutics (GTHP) Treasury Shares (2010 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 16 years of Treasury Shares data on file, last reported at $132000.0 in Q3 2025.
- For the quarter ending Q3 2025, Treasury Shares changed 0.0% year-over-year to $132000.0; the trailing twelve-month figure through Sep 2025 stood at $132000.0 (changed 0.0% YoY), and the FY2024 full-year result was $132000.0, changed 0.0% from the prior year.
- Treasury Shares was little changed at $132000.0 in Q3 2025, from $132000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $678000.0 in Q2 2021 to a low of $153000.0 in Q4 2021.
- A 4-year average of $640500.0 and a median of $678000.0 in 2021 frame the typical range for Treasury Shares.
- Peak annual rise in Treasury Shares reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
- Tracing GTHP's Treasury Shares over 5 years: stood at $132000.0 in 2021, then changed by 0.0% to $132000.0 in 2022, then changed by 0.0% to $132000.0 in 2023, then changed by 0.0% to $132000.0 in 2024, then changed by 0.0% to $132000.0 in 2025.
- Business Quant data shows GTHP's Treasury Shares at $132000.0 in Q3 2025, $132000.0 in Q2 2025, and $132000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 16.94 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 7.70 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 263.29 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 83.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 14.05 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.51 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 515.00 Mn |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 132,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 678,000.00 |
| Sep 30, 2024 | 678,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 678,000.00 |
| Jun 30, 2024 | 678,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Mar 31, 2024 | 132,000.00 |
| Mar 31, 2024 | 678,000.00 |
| Mar 31, 2024 | 678,000.00 |
| Mar 31, 2024 | 132,000.00 |